sustain 6 trial semaglutide π SUSTAIN-6 (NEJM 2016) β the safety that became a landmark., In 3,297 patients with type 2 diabetes at high CV risk, reduced:, β’ 3-point MACE 26% (HR 0.74), β’ Nonfatal stroke 39% Semaglutide (SUSTAIN and PIONEER) reduces
Pay in 4 interest-free payments of $5.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15









:max_bytes(150000):strip_icc()/Health-GettyImages-2177990872-3ef7dc37a7904ccb9ef456f494bc6348.jpg)













